|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-6-26
|
|
pubmed:abstractText |
We evaluated cyclosporine (CSA) dose reduction and mycophenolate mofetil (MMF) treatment versus maintained CSA dosage and azathioprine (AZA) in HTX regarding renal function and safety from CSA nephrotoxicity (creatinine > 1.7 mg/dL).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0041-1345
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1539-42
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12826215-Adult,
pubmed-meshheading:12826215-Aged,
pubmed-meshheading:12826215-Blood Urea Nitrogen,
pubmed-meshheading:12826215-Creatinine,
pubmed-meshheading:12826215-Cyclosporine,
pubmed-meshheading:12826215-Dose-Response Relationship, Drug,
pubmed-meshheading:12826215-Drug Therapy, Combination,
pubmed-meshheading:12826215-Female,
pubmed-meshheading:12826215-Heart Transplantation,
pubmed-meshheading:12826215-Humans,
pubmed-meshheading:12826215-Immunosuppressive Agents,
pubmed-meshheading:12826215-Kidney Function Tests,
pubmed-meshheading:12826215-Male,
pubmed-meshheading:12826215-Middle Aged,
pubmed-meshheading:12826215-Mycophenolic Acid,
pubmed-meshheading:12826215-Safety
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine.
|
|
pubmed:affiliation |
Department of Thoracic and Cardiovascular Surgery, Georg-August-University, Göttingen, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|
